Answers are grounded in this paper and cite their sources.
isperidone, a benzisoxazole derivative with high binding affinity for serotonergic 5-HT 2 and dopaminergic D 2 receptors, is becoming a first-line treatment for patients with schizophrenia.The pharmacology ofthis drug has been well described.•Risperidone has been found to be an effective antipsychotic agent with a relatively favorable side-effect profile, and there appears to be less risk for extrapyramidal symptoms and tardive dyskinesia compared to traditional neuroleptics.The efficacy of this drug has been tested in a variety of clinical trials in the United States, Canada, and abroad. 2Most of the pharmacological studies have involved comparisons between risperidone and other antipsychotic agents, including clozapine.The patients studied have most often had the diagnosis of schizophrenia.Less attention has been given to the use of risperidone in other psychotic disorders.The following report describes the use of risperidone to treat a patient with delusional parasitosis.
No takes yet. Share an insight, caveat, or question.
Gallucci et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: